Goldman Sachs
TNDM icon

Goldman Sachs’s Tandem Diabetes Care TNDM Stock Holding History

Goldman Sachs’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
862,301
-1,356,621
-61% -$23.7M ﹤0.01% 3025
2026
Q1 		$42.5M Buy
2,218,922
+535,522
+32% +$11.6M ﹤0.01% 1707
2025
Q4 		$37M Buy
1,683,400
+252,028
+18% +$4.55M ﹤0.01% 1759
2025
Q3 		$17.4M Sell
1,431,372
-455,103
-24% -$6.16M ﹤0.01% 2399
2025
Q2 		$35.2M Buy
1,886,475
+1,173,916
+165% +$23.3M ﹤0.01% 1614
2025
Q1 		$13.7M Buy
712,559
+34,069
+5% +$997K ﹤0.01% 2396
2024
Q4 		$24.4M Buy
678,490
+57,944
+9% +$1.96M ﹤0.01% 1914
2024
Q3 		$26.3M Buy
620,546
+428,822
+224% +$18.2M ﹤0.01% 1805
2024
Q2 		$7.72M Buy
191,724
+72,887
+61% +$3.04M ﹤0.01% 2755
2024
Q1 		$4.21M Sell
118,837
-106,888
-47% -$2.86M ﹤0.01% 3257
2023
Q4 		$6.68M Buy
225,725
+144,910
+179% +$3.01M ﹤0.01% 2904
2023
Q3 		$1.68M Sell
80,815
-3,017
-4% -$82.9K ﹤0.01% 3902
2023
Q2 		$2.06M Sell
83,832
-62,646
-43% -$2.02M ﹤0.01% 3857
2023
Q1 		$5.95M Sell
146,478
-195,216
-57% -$8.08M ﹤0.01% 2894
2022
Q4 		$15.4M Buy
341,694
+51,072
+18% +$2.31M ﹤0.01% 2191
2022
Q3 		$13.9M Sell
290,622
-336,664
-54% -$18.5M ﹤0.01% 2191
2022
Q2 		$37.1M Sell
627,286
-167,827
-21% -$13.8M 0.01% 1354
2022
Q1 		$92.5M Sell
795,113
-134,178
-14% -$15.7M 0.02% 805
2021
Q4 		$140M Sell
929,291
-53,455
-5% -$7.22M 0.03% 624
2021
Q3 		$117M Buy
982,746
+367,990
+60% +$40.5M 0.02% 661
2021
Q2 		$59.9M Buy
614,756
+79,129
+15% +$7.06M 0.01% 1106
2021
Q1 		$47.3M Sell
535,627
-72,955
-12% -$6.78M 0.01% 1213
2020
Q4 		$58.2M Sell
608,582
-6,552
-1% -$675K 0.02% 1007
2020
Q3 		$69.8M Sell
615,134
-87,534
-12% -$9.2M 0.02% 771
2020
Q2 		$69.5M Buy
702,668
+201,475
+40% +$16.1M 0.02% 741
2020
Q1 		$32.3M Sell
501,193
-249,233
-33% -$17.5M 0.01% 1168
2019
Q4 		$44.7M Buy
750,426
+134,544
+22% +$8.3M 0.01% 1229
2019
Q3 		$36.3M Buy
615,882
+42,722
+7% +$2.73M 0.01% 1334
2019
Q2 		$37M Sell
573,160
-9,868
-2% -$637K 0.01% 1369
2019
Q1 		$37M Buy
583,028
+67,723
+13% +$3.56M 0.01% 1358
2018
Q4 		$19.6M Sell
515,305
-280,280
-35% -$9.9M 0.01% 1824
2018
Q3 		$34.1M Buy
795,585
+784,485
+7,067% +$27.4M 0.01% 1502
2018
Q2 		$244K Buy
+11,100
New +$136K ﹤0.01% 4897
2017
Q3 		– Sell
-9,847
Closed -$79K – 6859
2017
Q2 		$79K Buy
+9,847
New +$91K ﹤0.01% 6216
2017
Q1 		– Sell
-3,207
Closed -$69K – 7002
2016
Q4 		$69K Buy
+3,207
New +$123K ﹤0.01% 6300
2016
Q2 		– Sell
-842
Closed -$73K – 7256
2016
Q1 		$73K Buy
+842
New +$73.7K ﹤0.01% 6246
2015
Q4 		– Sell
-3,574
Closed -$315K – 7341
2015
Q3 		$315K Sell
3,574
-855
-19% -$99.5K ﹤0.01% 5571
2015
Q2 		$480K Buy
4,429
+1,839
+71% +$229K ﹤0.01% 5254
2015
Q1 		$327K Sell
2,590
-7,749
-75% -$1.01M ﹤0.01% 5558
2014
Q4 		$1.31M Buy
+10,339
New +$1.43M ﹤0.01% 4265
2014
Q1 		– Sell
-31,270
Closed -$8.06M – 6932
2013
Q4 		$8.06M Buy
+31,270
New +$7.15M ﹤0.01% 2571

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Goldman Sachs's TNDM Position: Q2 2026 in Review

Goldman Sachs reduced its Tandem Diabetes Care (TNDM) stake by 61% in Q2 2026, selling an estimated $23.7M and leaving 862,301 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #3025.

Goldman Sachs first reported a position in TNDM in Q4 2013 and has held it in 41 quarters since. The position peaked at $140M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Goldman Sachs held 862,301 shares of Tandem Diabetes Care worth $13M as of Q2 2026.
  • Goldman Sachs sold 1,356,621 Tandem Diabetes Care shares in Q2 2026, an estimated $23.7M.
  • Tandem Diabetes Care made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3025 holding.
  • Goldman Sachs first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 41 quarters since.
  • Goldman Sachs's Tandem Diabetes Care position peaked at $140M in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.